STOCK TITAN

Syros Pharmaceuticals Inc. - SYRS STOCK NEWS

Welcome to our dedicated news page for Syros Pharmaceuticals (Ticker: SYRS), a resource for investors and traders seeking the latest updates and insights on Syros Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Syros Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Syros Pharmaceuticals's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.97%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
conferences clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.98%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.64%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.65%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.65%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.1%
Tags
conferences
Syros Pharmaceuticals Inc.

Nasdaq:SYRS

SYRS Rankings

SYRS Stock Data

139.14M
11.05M
1%
84.28%
6.69%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Cambridge

About SYRS

syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.